Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
Summary
IRVINE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management sol...
Description
IRVINE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management sol...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source